PMC:7172841 / 25816-26460 11 Projects
Annnotations
| Id | Subject | Object | Predicate | Lexical cue |
|---|---|---|---|---|
| T50203 | 39-47 | SP_7 | denotes | ignature |
| T815 | 51-57 | UBERON:0002405;GO:0006955 | denotes | immune |
| T816 | 58-71 | GO:0006955 | denotes | dysregulation |
| T817 | 93-103 | SP_7 | denotes | SARS-CoV-2 |
| T29702 | 148-153 | UBERON:0002405;GO:0006955 | denotes | high |
| T17561 | 154-167 | GO:0006955 | denotes | ytokine produ |
| T90888 | 189-199 | SP_7 | denotes | reased cir |
| T818 | 230-234 | PR:000001393 | denotes | IL-6 |
| T819 | 310-314 | PR:000001393 | denotes | IL-6 |
| T69958 | 326-330 | PR:000001393 | denotes | crea |
| T820 | 336-339 | PR:000029150 | denotes | HLA |
| T821 | 343-353 | GO:0010467 | denotes | expression |
| T56935 | 406-410 | PR:000001393 | denotes | inic |
| T72906 | 432-435 | PR:000029150 | denotes | acy |
| T21106 | 439-449 | GO:0010467 | denotes | Anakinra, |
| T822 | 449-458 | DG_39 | denotes | Sarilumab |
| T823 | 476-487 | DG_35 | denotes | Tocilizumab |
| T43307 | 546-555 | DG_39 | denotes | 298 and E |
| T89983 | 573-584 | DG_35 | denotes | -001039-29) |